COVID-19 Vaccine (Vero Cell), Inactivated [Covid-19 Vaccine Sinopharm] - Food and Drug Administration

COVID-19 Vaccine (Vero Cell), Inactivated [COVID-19 Vaccine Sinopharm]

COVID-19 Vaccine Sinopharm (Beijing)

On 10 September 2021, the Food and Drug Administration (FDA) issued authorization granting the Department of Health the emergency use approval of COVID-19 Vaccine (VeroCell), Inactivated [COVID-19 Vaccine Sinopharm (Beijing)].
Information on the safety of COVID-19 Vaccine Sinopharm is discussed in their comprehensive Risk Management Plan.
For more information on reporting side effects, click here.

COVID-19 Vaccine Sinopharm (Wuhan)

On 19 August 2021, the Food and Drug Administration (FDA) issued authorization granting 2 World Traders Inc. the emergency use approval of COVID-19 Vaccine (VeroCell), Inactivated [COVID-19 Vaccine Sinopharm (Wuhan)].

Product Information
English

Further, on 14 October 2021, the Food and Drug Administration (FDA) issued authorization granting Aisini International Trading the emergency use approval of COVID-19 Vaccine (VeroCell), Inactivated [COVID-19 Vaccine Sinopharm (COVIGEM)].
Information on the safety of COVID-19 Vaccine Sinopharm is discussed in their comprehensive Risk Management Plan.
For more information on reporting side effects, click here.

COVID-19 Vaccine Sinopharm (Hayat-Vax)

On 07 October 2021, the Food and Drug Administration (FDA) issued authorization (amended on 14 October 2021) granting Southmed Pharma Corporation the emergency use approval of Covid-19 Vaccine (VeroCell), Inactivated [COVID-19 Vaccine Sinopharm (Hayat-Vax)].

Product Information

English

Information on the safety of COVID-19 Vaccine Sinopharm is discussed in their comprehensive Risk Management Plan.
For more information on reporting side effects, click here.